Consistent with these findings, FL118 treatment of cancer cells inhibited BrdU label (proliferation, Fig. 3a, b) and increased the production of apoptotic markers including caspase-3 activation and PARP cleavage (Fig. 3c). The gene discussed is CASP3; the disease is cancer.